Month: July 2020

MONTREAL, July 14, 2020 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to announce today its financial and operational results for the first quarter ended March 31st, 2020.“Percent complete revenue recognition in our major projects, which is the revenue recognition method we are mandated to follow by GAAP, is such that it is not linear, but exponential, and as such Q1 2020 may not have reflected the results one might have expected given recent announcements. However, using this same revenue recognition method we can safely...

CHICAGO, July 14, 2020 (GLOBE NEWSWIRE) — GoHealth, Inc. (“GoHealth”) (Nasdaq: GOCO), a leading health insurance marketplace, today announced the pricing of its initial public offering of 43,500,000 shares of its Class A common stock at a public offering price of $21.00 per share. The underwriters will also have a 30-day option to purchase up to an additional 6,525,000 shares of Class A common stock at the initial public offering price, less the underwriting discount.The shares of Class A common stock are expected to begin trading on The Nasdaq Global Select Market under the ticker symbol “GOCO” on July 15, 2020. The offering is expected to close on July 17, 2020, subject to customary closing conditions.Goldman Sachs & Co. LLC, BofA Securities and Morgan Stanley are acting as managing bookrunners. Barclays, Credit Suisse, Evercore...

**Not for distribution to United States Newswire Services or release publication, distribution or dissemination, directly or indirectly, in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities Laws**CALGARY, Alberta and TORONTO, July 14, 2020 (GLOBE NEWSWIRE) — Magnetic North Acquisition Corp. (TSXV: MNC) (“Magnetic North” or the “Company”), along with Cirque Innovations Ltd. (“Cirque”), is pleased to launch commercial operations for CXTL Recycling Canada Corp. (“CXTL”). CXTL will use Cirque’s recycling technology to break down plastics into saleable products, leaving virtually no waste behind.The foundational technology which Mr. John Blair, CEO of Cirque, first invented in 1993, uses a patent-pending nano chemical process utilizing ultra-frequencies to depolymerize and break...

OTTAWA, July 14, 2020 (GLOBE NEWSWIRE) — Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV:CGP) (Frankfurt:GWN) (Berlin:GWN) (OTC:CTNXF) today announced that its Board of Directors, upon the unanimous recommendation of an independent committee of the Board (the “Independent Committee”) and following a detailed review conducted in consultation with its financial and legal advisors, has unanimously rejected SolGold plc’s (“SolGold”) unsolicited offer to acquire Cornerstone (the “Hostile Bid”) for the second time. The Hostile Bid was formalized by SolGold on June 30, 2020 nearly a year and a half after SolGold announced its intention to make an unsolicited offer to acquire Cornerstone. The Board previously announced its first rejection of the proposed bid as outlined in Cornerstone’s press release dated March...

CHICAGO, July 14, 2020 (GLOBE NEWSWIRE) — Royal Financial, Inc. (the “Company”) (OTCQX: RYFL), incorporated under the laws of Delaware on December 15, 2004, for the purpose of serving as the holding company of Royal Savings Bank (the “Bank”), announces the preliminary earnings results and statement of condition for the fiscal year ended 2020.Net income for the fourth quarter of fiscal 2020 was $1.0 million or $0.41 per share, compared to $874,000, or $0.34 per share, for the same period in fiscal 2019.  Net income for the year ended June 30, 2020, was $2.0 million, or $0.80 per share, compared to $3.7 million, or $1.46 per share in 2019.The Company also reported total assets of $434.1 million and stockholders’ equity of $42.8 million as of June 30, 2020. At June 30, 2020, the book value per common share, shares outstanding of 2,556,518,...

SYDNEY, Australia, July 15, 2020 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) announces the grant of patent no. 10,711,060 entitled “Antibody molecules to LAG-3 and uses thereof” by the United States Patent and Trade Mark Office.This new United States patent is directed to embodiments of LAG525, a humanised form of Immutep’s IMP701 antibody which is out-licensed to Novartis AG. In particular, the patent is directed to nucleic acid molecules that code for the LAG525 antibody, to expression vectors and host cells that comprise these nucleic acids, and to methods of producing the LAG525 antibody by culturing the host cells of the invention.The application was originally filed as a second divisional application and this grant follows the grant of the first divisional application, as announced...

MONACO, July 14, 2020 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announced that Scorpio Services Holdings Limited (“SSH”), a related party, has purchased 100,000 common shares of the Company in the open market at an average price of $12.83 per share.Additionally, the President of the Company, Robert Bugbee, has purchased call options on an aggregate of 550,000 common shares (or 5,500 call option contracts) of the Company for total consideration of $2.1 million.  Of these option contracts, 1,000 contracts have a strike price of $15.00 and an expiration of January 2021, and 4,500 contracts have a strike price of $18.00 and an expiration of January 2022.About Scorpio Tankers Inc.Scorpio Tankers is a provider of marine transportation of petroleum products worldwide. The Company’s fleet...

DAYTONA BEACH, Fla., July 14, 2020 (GLOBE NEWSWIRE) — CTO Realty Growth (NYSE American: CTO) (the “Company” or “CTO”) today announced the closing of the following three land sales transactions representing a total of approximately 3,110 acres and generating aggregate sales proceeds of approximately $42 million ( the “Land Sales”) to the Land Joint Venture that was formed in October 2019 (the “Land JV”):On July 14, 2020, completed the sale of approximately 3,015 acres, located on the west side of Interstate 95 (“I-95”), to an affiliate of SITEX Properties USA, including four separate land parcels, for total proceeds of approximately $40.9 million. The largest parcel of the four sold was previously under contract for the proposed second phase of the Latitude Margaritaville community;In early July 2020, completed the sale of approximately...

TORONTO, July 14, 2020 (GLOBE NEWSWIRE) — Hampton Financial Corporation (“Hampton” or the “Corporation”) (TSXV: HFC) (TSXV: HFC.PR.A) is pleased to announce that Mr. Duncan Webb will be joining the firm as President, Chief Operating Officer & Chief Financial Officer. Mr. Webb has a long history as a senior executive in Canada’s financial services industry. Prior to Joining Hampton, Mr. Webb served as Senior Vice President, Chief Financial Officer & Chief Administrative Officer with CIBC Mellon. Prior to this he served as Senior Vice President – Finance & Technology for the Ontario Pension Board. As well, he has served as Chief Compliance Officer for Credit Suisse Securities (Canada), and Chief Financial Officer for CT Securities Inc. Mr. Webb’s appointment adds significant depth to the Hampton management team and...

Angelini Pharma获得OV101（gaboxadol）开发、生产和商业化独家权利，用于欧盟、欧洲经济区其他国家以及瑞士、土耳其、英国和俄罗斯天使综合征患者的潜在治疗 Ovid Therapeutics将获得2000万美元前期付款并将在实现开发、制造和销售里程碑后再获得高达2.125亿美元的付款；此外如成功实现商业化还将获得净销售额两位数百分比的特许权收入 Angelini Pharma将通过其新成立的附属机构Angelini Pharma Rare Diseases AG来执行该项协议 Ovid将于今天上午8:15举行电话会议和网络直播 EDT纽约和罗马, July 15, 2020 (GLOBE NEWSWIRE) — 致力于开发药品以改进罕见神经系统疾病患者生活的生物制药企业Ovid Therapeutics Inc.（纳斯达克：OVID，以下称“Ovid”）与长期广泛关注精神健康、罕见病和消费者健康并致力于帮助患者的意大利家族制药企业Angelini Pharma S.p.A.（以下称“Angelini Pharma”）宣布签署协议，由Angelini Pharma负责OV101（gaboxadol）的开发、制造和商业化，作为欧盟和欧洲经济区其他国家以及瑞士、土耳其、英国及俄罗斯地区天使综合征的潜在治疗方法。Angelini Pharma将通过其新设立的附属机构Angelini Pharma Rare Diseases AG执行本协议。OV101被认为是开发中的唯一一种delta (δ)选择性GABAA受体激动剂，目前正在天使综合征关键的第三期NEPTUNE试验中进行评估，预计将在2020年第四季度获得顶线试验结果。根据协议条款， Ovid将获得2000万美元前期付款，并将在实现开发、制造以及针对首个适应症（天使综合征）的销售后获得高达2.125亿美元的付款；而如果OV101成功实现商业化则可获得相当于净销售额两位数百分比的特许费。Ovid将保留OV101在美国和世界其他地区的全部商业权利。“我们很高兴能与Angelini...